These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12351944)

  • 21. Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Martinez P; Kuroda M; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):255-66. PubMed ID: 14600569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
    Kundu SK; Merigan TC
    AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
    Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
    AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.
    Loffredo JT; Burwitz BJ; Rakasz EG; Spencer SP; Stephany JJ; Vela JP; Martin SR; Reed J; Piaskowski SM; Furlott J; Weisgrau KL; Rodrigues DS; Soma T; Napoé G; Friedrich TC; Wilson NA; Kallas EG; Watkins DI
    J Virol; 2007 Mar; 81(6):2624-34. PubMed ID: 17192314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
    Scott-Algara D; Buseyne F; Blanche S; Rouzioux C; Jouanne C; Romagné F; Rivière Y
    J Infect Dis; 2001 Jun; 183(11):1565-73. PubMed ID: 11343205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection.
    Sester M; Sester U; Köhler H; Schneider T; Deml L; Wagner R; Mueller-Lantzsch N; Pees HW; Meyerhans A
    AIDS; 2000 Dec; 14(17):2653-60. PubMed ID: 11125883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.
    Rinaldo CR; Huang XL; Fan Z; Margolick JB; Borowski L; Hoji A; Kalinyak C; McMahon DK; Riddler SA; Hildebrand WH; Day RB; Mellors JW
    J Virol; 2000 May; 74(9):4127-38. PubMed ID: 10756025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.
    Novitsky V; Gilbert P; Peter T; McLane MF; Gaolekwe S; Rybak N; Thior I; Ndung'u T; Marlink R; Lee TH; Essex M
    J Virol; 2003 Jan; 77(2):882-90. PubMed ID: 12502804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
    Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.
    Thomas AS; Jones KL; Gandhi RT; McMahon DK; Cyktor JC; Chan D; Huang SH; Truong R; Bosque A; Macedo AB; Kovacs C; Benko E; Eron JJ; Bosch RJ; Lalama CM; Simmens S; Walker BD; Mellors JW; Jones RB
    PLoS Pathog; 2017 Sep; 13(9):e1006629. PubMed ID: 28931091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
    López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal antigens for HIV vaccines based on CD8+ T response, protein length, and sequence variability.
    Betts MR; Yusim K; Koup RA
    DNA Cell Biol; 2002 Sep; 21(9):665-70. PubMed ID: 12396609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.
    Ruiz L; Martinez-Picado J; Romeu J; Paredes R; Zayat MK; Marfil S; Negredo E; Sirera G; Tural C; Clotet B
    AIDS; 2000 Mar; 14(4):397-403. PubMed ID: 10770542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.
    Kavanagh DG; Kaufmann DE; Sunderji S; Frahm N; Le Gall S; Boczkowski D; Rosenberg ES; Stone DR; Johnston MN; Wagner BS; Zaman MT; Brander C; Gilboa E; Walker BD; Bhardwaj N
    Blood; 2006 Mar; 107(5):1963-9. PubMed ID: 16249391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection.
    Geldmacher C; Gray C; Nason M; Currier JR; Haule A; Njovu L; Geis S; Hoffmann O; Maboko L; Meyerhans A; Cox J; Hoelscher M
    J Virol; 2007 Dec; 81(24):13809-15. PubMed ID: 17898052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.